-
Zydus Cadila’s Virafin gets emergency authorisation for COVID-19 treatment
A single-dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients, Zydus Cadila said
-
Sputnik V: Russian Direct Investment Fund says India to produce over 850 million doses
Sputnik V will be the third vaccine to be used in India
-
Covid-19: Expert panel recommends approval to Sputnik V vaccine for emergency use
The Drugs Controller General of India will take a final call on the recommendation. If approved, Sputnik V will be the third COVID-19 vaccine to be av
-
WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date
-
COVID-19: Government’s expert panel allows clinical trials for third dose of Covaxin
Bharat Biotech presented amendments to the subject expert committee of DCGI in the approved Phase 2 clinical trial protocol for administration of boos
